AARTI PHARMALABS LTDAARTI PHARMALABS LTDAARTI PHARMALABS LTD

AARTI PHARMALABS LTD

No trades
See on Supercharts
Market capitalization
‪62.34 B‬INR
25.15INR
‪2.17 B‬INR
‪18.18 B‬INR
‪49.54 M‬
Beta (1Y)
0.71
Employees (FY)
‪3.18 K‬
Change (1Y)
+275 +9.46%
Revenue / Employee (1Y)
‪68.48 K‬INR
Net income / Employee (1Y)
‪8.17 K‬INR

About AARTI PHARMALABS LTD


Headquarters
Mumbai
Founded
2019
ISIN
INE0LRU01027
FIGI
BBG01B1YBKP4
Aarti Pharmalabs Ltd. engages in the manufacture and sale of pharmaceutical and nutraceutical products. It offers active pharmaceutical ingredients, pharmaceutical intermediates, new chemical entities, and xathine derivatives. The company was founded on November 22, 2019 and is headquartered in Mumbai, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of AARTIPHARM is 658.75 INR — it has decreased by −4.27% in the past 24 hours. Watch AARTI PHARMALABS LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange AARTI PHARMALABS LTD stocks are traded under the ticker AARTIPHARM.
AARTIPHARM stock has risen by 1.83% compared to the previous week, the month change is a 9.18% rise, over the last year AARTI PHARMALABS LTD has showed a 67.45% increase.
AARTIPHARM reached its all-time high on Aug 29, 2024 with the price of 721.70 INR, and its all-time low was 234.80 INR and was reached on Feb 3, 2023. View more price dynamics on AARTIPHARM chart.
See other stocks reaching their highest and lowest prices.
AARTIPHARM stock is 5.62% volatile and has beta coefficient of 0.71. Track AARTI PHARMALABS LTD stock price on the chart and check out the list of the most volatile stocks — is AARTI PHARMALABS LTD there?
Yes, you can track AARTI PHARMALABS LTD financials in yearly and quarterly reports right on TradingView.
AARTIPHARM net income for the last quarter is ‪546.23 M‬ INR, while the quarter before that showed ‪554.53 M‬ INR of net income which accounts for −1.50% change. Track more AARTI PHARMALABS LTD financial stats to get the full picture.
AARTI PHARMALABS LTD dividend yield was 0.69% in 2023, and payout ratio reached 12.53%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 8, 2024, the company has ‪3.18 K‬ employees. See our rating of the largest employees — is AARTI PHARMALABS LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AARTI PHARMALABS LTD EBITDA is ‪4.03 B‬ INR, and current EBITDA margin is 19.51%. See more stats in AARTI PHARMALABS LTD financial statements.
Like other stocks, AARTIPHARM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AARTI PHARMALABS LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AARTI PHARMALABS LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AARTI PHARMALABS LTD stock shows the buy signal. See more of AARTI PHARMALABS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.